Genocury Biotech Ltd. is a R&D biotechnology corporation, which commits to the research of cell and gene therapies(CGT) targeting various tumor, we also hope to offer the most promising geneeral treatment therapy options. The R&D team of Genocury are all experienced personnel in the field of CGT. Independently, they has already built an in-vivo CAR-T technology platform, and iPS reprogramming and directional differentiation platform. Right now, Genocury is actively promoting multiple cell products into clinical studies.
TGenecury Biotech Ltd. hopes to make genotherapy accessible to the vast majority of patients suffering from diseases like cancer through innovation and to take on significant social responsibility. In addition, we offer services and add value for our clients with honesty and integrity. We also foster a positive work atmosphere and give employees a wide range of opportunities to use their talents.